Cargando…
Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel
Aim: Chemoresistance is a prevalent issue in cancer treatment. Paclitaxel (PTX) is a microtubule-binding anticancer drug used in various cancer treatments. However, cancer cells often show chemoresistance against PTX with the help of P-glycoprotein (Pgp) - a drug efflux pump. It has also been observ...
Autores principales: | Kumari, Neema, Giri, Pravin Shankar, Rath, Subha Narayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992437/ https://www.ncbi.nlm.nih.gov/pubmed/35582374 http://dx.doi.org/10.20517/cdr.2021.54 |
Ejemplares similares
-
Are calcium channel blockers related to lung cancer?
por: Rattanathanoo, Ratchanon, et al.
Publicado: (2023) -
Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009) -
An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015) -
The role of calcium channel blockers in wound healing
por: Mojiri-Forushani, Hoda
Publicado: (2018) -
Diindolylmethane Derivatives: New Selective Blockers for T-Type Calcium Channels
por: Wang, Dan, et al.
Publicado: (2022)